This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
250
Radical resection of hepatocellular carcinoma
Implanted during the surgical treatment
Eastern Hepatobiliary Surgery Hospital
Shanghai, China
RECRUITINGTo assess the clinical benefit of fluorouracil implants regional chemotherapy during the radical resection in early stage hepatocellular carcinoma patients. The primary endpoint is disease-free survival (DFS).
Time frame: 1, 2, and 3 years
Quality of Life
Time frame: from baseline to the last visit
Incidence Rate of Complications
Time frame: 1, 2, and 3 years
Adverse Events
Time frame: from the beginning of treatment to the end of study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.